In this episode of TDR Trade to Black, host Shadd Dales sits down with Avicanna Inc. (TSX: AVCN) CEO Aras Azadian and Dr. Hance Clarke (President, Canadian Pain Society; physician at Toronto General Hospital) to break down a new peer-reviewed medical cannabis study published in the Canadian Journal of Pain.The discussion focuses on a 24-week real-world evidence study that followed patients authorized medical cannabis by healthcare professionals, tracking outcomes across pain, anxiety, sleep, disability, and overall quality of life. The takeaway is clear: results were cautious, clinically grounded, and directionally positive — the kind of “honest data” physicians and policymakers need to move from stigma to standards.Shadd, Aras, and Dr. Clarke also explain why Canada’s federally regulated medical framework has enabled faster research progress over the last decade — and why that matters with U.S. rescheduling still trending toward a more medical, FDA-influenced pathway. The conversation highlights the difference between adult-use retail behavior and true medical cannabis, where dosing, patient monitoring, clinician involvement, and reproducible outcomes become the whole game.For investors, operators, and policy watchers, this episode outlines what U.S. companies may underestimate if rescheduling accelerates: medical credibility isn’t just a product story — it’s a service model, a clinical pathway, and an evidence engine. And Canada may be one of the most important guides for what comes next.#Avicanna #AVCN #MedicalCannabis #CannabisResearch #CanadianJournalOfPain #PainManagement #RealWorldEvidence #CannabisPolicy #CannabisRescheduling #TradeToBlackWant to see more Cannabis Reform videos?🎬 • Virginia Is Finally Getting Serious About ... 🎬 • Why Washington Still Bans Homegrown Cannab... 🎬 • Who’s Trying to Undo Legal Cannabis? | TDR... Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook: / thedalesreport ✅ Twitter: / thedalesreport ✅ Instagram: / dalesreport ✅ LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...